César Augusto
Rodríguez Sánchez
Profesor Asociado CC. Salud
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublications en collaboration avec des chercheurs de Instituto de Investigación Biomédica de Salamanca (7)
2023
2020
-
Stromal SNAI2 is required for ERBB2 breast cancer progression
Cancer Research, Vol. 80, Núm. 23, pp. 5216-5230
2019
-
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Aging, Vol. 11, Núm. 9, pp. 2874-2888
-
Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer
Journal of Clinical Medicine, Vol. 8, Núm. 12
-
The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin
Frontiers in Oncology, Vol. 9, Núm. MAR
2018
-
A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study
Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704
2015
-
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach
Genome Biology, Vol. 16, Núm. 1